Sandoz Group (SDZNY) Stock Price, News & Analysis

Company Overview

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

Key Stats

• Today's Range: $60.77 to $62.86
• 50-Day Range: $50.76 to $62.41
• 52-Week Range: $35.61 to $62.86
• Volume: 24,850 shs
• Average Volume: 20,778 shs
• Market Capitalization: $27.46 billion
• P/E Ratio: N/A
• Dividend Yield: 0.71%
• Price Target: N/A
• Consensus Rating: Hold

Sandoz Group Stock Analysis - MarketRank™

Sandoz Group scored higher than 43% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Sandoz Group.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 22.96%

Earnings Growth

Earnings for Sandoz Group are expected to grow by 22.96% in the coming year, from $2.70 to $3.32 per share.

Price to Earnings Growth Ratio

Sandoz Group has a PEG Ratio of 0.97. PEG Ratios around 1 indicate that a company is correctly valued.

Price to Book Value per Share Ratio

Sandoz Group has a P/B Ratio of 3.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the outstanding shares of Sandoz Group have been sold short.

Short Interest Ratio / Days to Cover

Sandoz Group has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sandoz Group has recently increased by 8.03%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Sandoz Group has a dividend yield of 0.79%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Sandoz Group does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Sandoz Group will have a dividend payout ratio of 13.25% next year. This indicates that Sandoz Group will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.01% of the outstanding shares of Sandoz Group have been sold short.

Short Interest Ratio / Days to Cover

Sandoz Group has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sandoz Group has recently increased by 8.03%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 0.55

News Sentiment

Sandoz Group has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Sandoz Group this week, compared to 1 article on an average week.

MarketBeat Follows

1 people have added Sandoz Group to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sandoz Group insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 0.06% of the stock of Sandoz Group is held by institutions.

SDZNY Stock Analysis - Frequently Asked Questions

How have SDZNY shares performed this year?

Sandoz Group's stock was trading at $40.50 on January 1st, 2025. Since then, SDZNY stock has increased by 54.1% and is now trading at $62.41.

How do I buy shares of Sandoz Group?

Shares of SDZNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 8/08/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SDZNY
• CIK: 1992829
• Web: www.sandoz.com
• Phone: 41-61-324-11-11
• Fax: N/A
• Employees: 23,406
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 23.11
• P/E Growth: 0.97
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.57
• Current Ratio: 1.24
• Quick Ratio: 0.79

Sales & Book Value

• Annual Sales: $10.36 billion
• Price / Sales: 2.65
• Cash Flow: $2.98 per share
• Price / Cash Flow: 20.92
• Book Value: $18.56 per share
• Price / Book: 3.36

Miscellaneous

• Outstanding Shares: 440,000,000
• Free Float: N/A
• Market Cap: $27.46 billion
• Optionable: Not Optionable
• Beta: 0.60